PropertyValue
?:abstract
  • Corticosteroids have potent anti-inflammatory and immunosuppressive effects. Recently, these medications have gained importance in the treatment of severe COVID-19. Here we present data demonstrating a marked (10-fold) increase in frequency of candidemia in hospitalized patients with COVID-19 receiving corticosteroids in Brazil. Overall mortality was 72.7%, despite antifungal therapy. Physicians should be aware of the potential risk for candidemia among severely ill COVID-19 patients receiving high-doses of corticosteroids.
is ?:annotates of
?:creator
?:doi
  • 10.3390/jof6040286
?:doi
?:journal
  • J_Fungi_(Basel)
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/9abf1e60ae2bf2385b5f8fca1168205970caf49a.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7712895.xml.json
?:pmcid
?:pmid
?:pmid
  • 33203016.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Is the Frequency of Candidemia Increasing in COVID-19 Patients Receiving Corticosteroids?
?:type
?:year
  • 2020-11-13

Metadata

Anon_0  
expand all